Change in Qrs Duration Asa Predictor for Response to Sacubitril/valsartan in Heart Failure With Reduced Ejection Fraction

被引：0
|
作者：
Kim, Bong Joon
Park, Han Su
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12683
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction
    Greene, Stephen J.
    Fonarow, Gregg C.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2994 - 2997
  • [22] Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction
    Muhammad Nauman Khan
    Najia Aslam Soomro
    Khalid Naseeb
    Usman Hanif Bhatti
    Rubina Rauf
    Iram Jehan Balouch
    Ali Moazzam
    Sonia Bashir
    Tariq Ashraf
    Musa Karim
    BMC Cardiovascular Disorders, 23
  • [23] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [24] Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Godet, M.
    Raitiere, O.
    Chopra, H.
    Guignant, P.
    Fauvel, C.
    Gaudin, K.
    Eltchaninoff, H.
    Beuer, F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 735 - 735
  • [25] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [26] QRS duration and mortality in heart failure with preserved and reduced ejection fraction
    Yap, J.
    Shen, T.
    Lam, C. S. P.
    Chia, S. Y.
    Jaufeerally, F. R.
    Ong, W.
    Sim, L. L.
    Lim, C. P.
    Sim, D.
    Ching, C. K.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1320 - 1320
  • [27] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
  • [28] Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry
    Maggioni, Aldo P.
    Clark, Andrew L.
    Barrios, Vivencio
    Damy, Thibaud
    Drozdz, Jaroslaw
    Fonseca, Candida
    Lund, Lars H.
    Kalus, Stefanie
    Ferber, Philippe C.
    Hussain, Rizwan, I
    Koch, Cornelia
    Zeymer, Uwe
    ESC HEART FAILURE, 2022, 9 (06): : 4209 - 4218
  • [29] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [30] Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context
    D'Angiolella, Lucia S.
    Cortesi, Paolo A.
    Pitotti, Claudia
    Ritrovato, Daniela
    Mantovani, Lorenzo G.
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1551 - 1553
12345